(Q39568963)

13 September 2017

Down-regulation of BMI-1 cooperates with artemisinin on growth inhibition of nasopharyngeal carcinoma cells (English)

1 reference

13 September 2017

0 references

Jing Wu

1

1 reference

13 September 2017

Dong Hu

2

1 reference

13 September 2017

Guang Yang

3

1 reference

13 September 2017

Junyi Zhou

4

1 reference

13 September 2017

Changfu Yang

5

1 reference

13 September 2017

Yun Gao

6

1 reference

13 September 2017

Zhenyu Zhu

7

1 reference

13 September 2017

language of work or name

1 reference

1 July 2011

1 reference

Journal of Cellular Biochemistry

13 September 2017

1 reference

13 September 2017

112

1 reference

13 September 2017

7

1 reference

13 September 2017

1938-1948

1 reference

Cyclin-dependent kinase inhibitors (CKIs) and hematological malignancies

13 September 2017

1 reference

Treatment approaches to nasopharyngeal carcinoma: a review.

21 January 2018

1 reference

The effect of combinations of qinghaosu (artemisinin) with standard antimalarial drugs in the suppressive treatment of malaria in mice

21 January 2018

1 reference

Inhibitory effects of artesunate on angiogenesis and on expressions of vascular endothelial growth factor and VEGF receptor KDR/flk-1.

21 January 2018

1 reference

Growth inhibitory effects of dihydroartemisinin on pancreatic cancer cells: involvement of cell cycle arrest and inactivation of nuclear factor-kappaB.

21 January 2018

1 reference

Bmi-1 regulates the Ink4a/Arf locus to control pancreatic beta-cell proliferation

21 January 2018

1 reference

Artemisinin (qinghaosu)--a new gametocytocidal drug for malaria

21 January 2018

1 reference

Molecular pharmacology and pharmacogenomics of artemisinin and its derivatives in cancer cells

21 January 2018

1 reference

Enhancement of cytotoxicity of artemisinins toward cancer cells by ferrous iron

21 January 2018

1 reference

Anticancer activities of artemisinin and its bioactive derivatives

21 January 2018

1 reference

Mel-18, a polycomb group protein, regulates cell proliferation and senescence via transcriptional repression of Bmi-1 and c-Myc oncoproteins

21 January 2018

1 reference

Novel zinc finger gene implicated as myc collaborator by retrovirally accelerated lymphomagenesis in E mu-myc transgenic mice.

21 January 2018

1 reference

The anti-malaria agent artesunate inhibits expression of vascular endothelial growth factor and hypoxia-inducible factor-1α in human rheumatoid arthritis fibroblast-like synoviocyte.

21 January 2018

1 reference

Bmi-1 over-expression in neural stem/progenitor cells increases proliferation and neurogenesis in culture but has little effect on these functions in vivo

21 January 2018

1 reference

Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6

21 January 2018

1 reference

Experimental Therapy of Hepatoma with Artemisinin and Its Derivatives: In vitro and In vivo Activity, Chemosensitization, and Mechanisms of Action

21 January 2018

1 reference

Anticancer and antiinflammatory activities of cucurbitacins from Cucurbita andreana

21 January 2018

1 reference

Qinghaosu (artemisinin): an antimalarial drug from China

21 January 2018

1 reference

Genetic and epigenetic changes in nasopharyngeal carcinoma.

21 January 2018

1 reference

The chemistry, pharmacology, and clinical applications of qinghaosu (artemisinin) and its derivatives

21 January 2018

1 reference

Growth inhibition and cell-cycle arrest of human gastric cancer cells by Lycium barbarum polysaccharide

21 January 2018

1 reference

Bmi-1 promotes neural stem cell self-renewal and neural development but not mouse growth and survival by repressing the p16Ink4a and p19Arf senescence pathways

21 January 2018

1 reference

Effect of artemisinin derivatives on apoptosis and cell cycle in prostate cancer cells

21 January 2018

1 reference

Transferrin receptor-dependent cytotoxicity of artemisinin-transferrin conjugates on prostate cancer cells and induction of apoptosis

21 January 2018

1 reference

Artemisinin induces doxorubicin resistance in human colon cancer cells via calcium-dependent activation of HIF-1alpha and P-glycoprotein overexpression.

21 January 2018

1 reference

Raf kinase inhibitor protein correlates with sensitivity of nasopharyngeal carcinoma to radiotherapy

21 January 2018

1 reference

Implication of polycomb members Bmi-1, Mel-18, and Hpc-2 in the regulation of p16INK4a, p14ARF, h-TERT, and c-Myc expression in primary breast carcinomas.

21 January 2018

1 reference

Bmi-1 is a novel molecular marker of nasopharyngeal carcinoma progression and immortalizes primary human nasopharyngeal epithelial cells

21 January 2018

1 reference

Nasopharyngeal carcinoma: molecular pathogenesis and therapeutic developments

21 January 2018

1 reference

Detection of Epstein-Barr Virus DNA in well and poorly differentiated nasopharyngeal carcinoma cell lines

21 January 2018

1 reference

Oncoprotein BMI-1 induces the malignant transformation of HaCaT cells

21 January 2018

1 reference

Artemisinin blocks prostate cancer growth and cell cycle progression by disrupting Sp1 interactions with the cyclin-dependent kinase-4 (CDK4) promoter and inhibiting CDK4 gene expression.

21 January 2018

1 reference

Natural compounds with proteasome inhibitory activity for cancer prevention and treatment

21 January 2018

1 reference

Molecular mechanism of anti-prostate cancer activity of Scutellaria baicalensis extract

21 January 2018

1 reference

Sesamin, a lignan of sesame, down-regulates cyclin D1 protein expression in human tumor cells

21 January 2018

1 reference

Epstein-Barr virus and oncogenesis: from latent genes to tumours

21 January 2018

1 reference

The traditional Chinese herbal compound rocaglamide preferentially induces apoptosis in leukemia cells by modulation of mitogen-activated protein kinase activities

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JCB.23114

1 reference

13 September 2017

1 reference